For Physicians and Clinics
The freedom to treat complex PAD hip to heel
Unprecedented flexibility in a single, streamlined device
FreedomFlow’s unique mechanism of action, adjustable speed, and ease of use provides greater versatility and efficiency in treating multiple arteries, lesions, and vessel diameters—all with a single device.
With two catheter sizes and two rotational speeds, a flexible driveshaft, and diamond-coated tip, the FreedomFlow platform gives physicians the freedom to help patients in new ways—even treating multiple blockages in the same vessel with the same device, from the common femoral to the distal tibial arteries.
The electric motor also provides smooth acceleration and enhances the physician’s tactile feel for predictable plaque modification.
In short, FreedomFlow is a simple yet effective platform that provides physicians and their patients with better treatment options.
SFA Angiography
Baseline
Final
Two rotational speeds
Flexible driveshaft
Diamond-coated tip
Freedom and flow for physicians and clinics
Time savings and cost efficiencies in a simple yet effective platform
FreedomFlow’s modern, streamlined platform offers time savings and cost efficiencies—with no capital equipment, no lubricant, and reduced inventory needs. It also provides faster procedural run times, consistent treatment outcomes, and a nearly flat learning curve for physicians.
With two basic catheter SKUs and a simple set-up with saline—together with the flexibility to treat a range of vessel sizes—FreedomFlow offers compelling productivity, consistent and predictable plaque modification or removal, and enhanced patient safety for today’s hospitals, ambulatory surgery centers, and office-based labs.
Single-use disposable
No capital equipment
No lubricant
Reduced inventory
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
INDICATIONS FOR USE: The Cardio Flow FreedomFlow® Orbital Atherectomy Peripheral Platform is indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries. The therapy is intended for patients who are acceptable candidates for percutaneous transluminal atherectomy.